ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3,2,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
3,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Sinus arrest,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
7,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
10,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
10,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,5,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
10,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
10,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10,9,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
10,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
10,11,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
10,12,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
10,13,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
11,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
11,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
12,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
13,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
14,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
14,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
15,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
15,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
16,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
16,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
16,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
16,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
17,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
17,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
17,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
18,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
18,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
18,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
18,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
18,7,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
18,8,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
18,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
18,10,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
18,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
19,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
20,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
20,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
20,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
21,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
21,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
22,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
22,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
22,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
22,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
23,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
23,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
23,3,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
23,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,5,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
23,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
23,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
23,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
23,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
23,10,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
24,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
25,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
25,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
25,3,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
26,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
26,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
26,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
26,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
27,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
27,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
27,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
27,5,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
27,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
28,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
28,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
30,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
30,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
30,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
31,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
32,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
32,3,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
32,4,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
32,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
32,6,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
32,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,8,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
32,9,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
32,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
32,11,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
32,12,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
32,13,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
32,14,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
32,15,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
32,16,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
32,17,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
32,18,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
32,19,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
32,20,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
33,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
33,2,Alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
33,3,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
33,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
33,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,8,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
33,9,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
33,10,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,11,Mental status changes postoperative,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
33,12,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
33,13,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
33,14,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
33,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
33,16,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
33,17,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
34,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
34,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
34,3,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
34,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
35,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
35,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
35,3,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
35,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
36,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
36,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
36,3,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
36,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,6,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
36,7,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
36,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
36,9,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
36,10,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
37,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
38,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
38,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
39,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
40,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
40,2,Tryptase increased,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
41,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
42,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
42,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
42,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
42,4,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
42,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
42,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
42,7,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
42,8,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
43,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
43,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
43,4,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
43,5,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
43,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
44,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
44,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
45,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
45,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
45,3,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
45,4,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
45,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
46,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
46,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
47,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
47,3,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
48,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
49,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
49,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
49,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
50,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
51,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
51,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
51,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
52,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
53,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,2,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
54,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
54,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
54,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
54,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
54,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,6,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
54,7,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
54,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
54,9,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,10,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
54,11,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
54,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
55,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
56,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
57,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
58,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
58,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
59,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
60,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
61,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
62,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
62,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
62,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
62,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
62,5,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
62,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
62,7,Muscle tone disorder,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
62,8,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
62,9,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,Y
63,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
64,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
64,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
64,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
66,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
66,3,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
67,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
68,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
69,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
70,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
70,2,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
71,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
71,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
71,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
71,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
72,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
72,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
72,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
72,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
72,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
72,7,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
72,8,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
73,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
74,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
75,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
76,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
76,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
76,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
76,5,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
76,6,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
76,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,8,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
77,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
77,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
78,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
79,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
79,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
79,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
79,4,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
79,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
81,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
82,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
83,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
84,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
85,1,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
86,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
86,2,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
87,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
88,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
89,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
90,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
91,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
92,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
92,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
93,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
94,1,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
94,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
94,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
94,4,Testicular injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
95,1,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
95,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
95,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
95,4,Testicular injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
96,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
96,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
97,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
98,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
98,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
99,1,Labelled drug-disease interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
99,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
